Uridine-5′-triphosphoric acid trisodium salt

We are Uridine-5′-triphosphoric acid trisodium salt CAS:19817-92-6 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:Uridine-5'-triphosphoric acid trisodium salt
CAS.NO:19817-92-6
Synonyms:UTP,Trisodium Salt
Uridine-5'-triphosph
URIDINE 5'-TRIPHOSPHATE TETRASODIUM
utp na3
uridin-5'-triphosphate trisodium salt
Molecular Formula:C9H12N2Na3O15P3
Molecular Weight:550.08700
 
Physical and Chemical Properties:
Density:2.106
Melting point:140ºC
Flash point:113 ºC
 
Specification:
Appearance:White powder
Assay(HPLC):≥98.0%
Assay(UV):≥95.0%
Moisture:≤15%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:A polyphosphate analogue of the nucleoside uridine used in the preparation of potent and selective agonists at the G-protein-coupled P2Y receptors.

Uridine-5'-triphosphoric acid trisodium salt


Related News: The upstream of pharmaceutical intermediates is the basic chemical raw material industry. Basic chemical raw materials are bulk commodities and prices fluctuate greatly, which directly affects the production costs of enterprises.2-Aminoisonicotinic acid Active pharmaceutical ingredients directly impact disease.1-Chloro-2-iodoethane CAS:624-70-4 Active pharmaceutical ingredients directly impact disease.7473-98-5 As proof-of-principle for the unique advantages arising from selecting a single engineered iPSC clone for the production of CAR T-cell therapy, the scientists assessed 747 clones after engineering a pool of cells using CRISPR. It was found that only about 2% of clones met the Company’s standards for overall quality including containing both bi-allelic disruption of the TCR, proper insertion of the CAR into the TRAC locus without random transgene integrations, and no evidence of off-target genomic modifications or translocations.As proof-of-principle for the unique advantages arising from selecting a single engineered iPSC clone for the production of CAR T-cell therapy, the scientists assessed 747 clones after engineering a pool of cells using CRISPR. It was found that only about 2% of clones met the Company’s standards for overall quality including containing both bi-allelic disruption of the TCR, proper insertion of the CAR into the TRAC locus without random transgene integrations, and no evidence of off-target genomic modifications or translocations.

Related Products
Product Name
N-Boc-L-glutamic Acid 5-Cyclohexyl Ester View Details
Methyl 3-carbamimidamido-4-methylbenzoate nitrate (1:1) View Details
4-Aminobenzonitrile View Details
adenine arabinoside manufacturer 4-Amino-2,3-dichlorophenol manufacturer 5-Bromo-2-Hydroxy-3-Picoline manufacturer (3R,4R)-1-Benzyl-N,4-dimethylpiperidin-3-amine dihydrochloride manufacturer (R,E)-5-([1,1′-biphenyl]-4-yl)-4-((tert-butoxycarbonyl)amino)-2-methylpent-2-enoic acid manufacturer